Who Owns Dr. Reddy's Laboratories Stock?
NYSE: RDYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 16.00%
- Held by insiders
- 0.00%
- Institutional holders
- 327
- Institutions 16.0%
- Insiders 0.0%
- Public and other 84.0%
Who owns Dr. Reddy's Laboratories stock?
Institutional investors own about 16.0% of Dr. Reddy's Laboratories's shares, spread across 327 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of RDY.
The largest institutional holders are Robeco Institutional Asset Management B.V. (2.16%), Morgan Stanley (1.31%) and Blackrock Inc. (1.27%). Together, the top 10 institutions control 9.8% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their RDY positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RDY
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Robeco Institutional Asset Management B.V. | 18.02M | 2.16% | +4.9% |
| Morgan Stanley | 10.94M | 1.31% | +16.7% |
| Blackrock Inc. | 10.59M | 1.27% | -8.6% |
| Royal Bank of Canada | 9.21M | 1.10% | -7.7% |
| Aikya Investment Management Ltd | 8.49M | 1.02% | +6.2% |
| Renaissance Technologies, LLC | 7.35M | 0.88% | -6.5% |
| Dimensional Fund Advisors LP | 5.31M | 0.64% | -0.2% |
| State Street Corporation | 4.12M | 0.49% | +2.5% |
| JPMORGAN CHASE & CO | 4.07M | 0.49% | -6.9% |
| Alliancebernstein L.P. | 3.73M | 0.45% | +46.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RDY
| Fund | Shares | % Held |
|---|---|---|
| iShares, Inc.-iShares Core MSCI Emerging Markets ETF | 5.74M | 0.69% |
| AB Funds-AB Emerging Markets Opportunities ETF | 3.74M | 0.45% |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | 2.03M | 0.24% |
| VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd | 1.87M | 0.22% |
| American Century ETF Trust-Avantis Emerging Markets Equity ETF | 1.81M | 0.22% |
| SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Emerging Markets ETF | 1.46M | 0.18% |
| VANGUARD WHITEHALL FUNDS-Vanguard Global Minimum Volatility Fund | 1.37M | 0.16% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT. | 1.35M | 0.16% |
| iShares, Inc.-iShares MSCI Emerging Markets ex China ETF | 1.28M | 0.15% |
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 874.07K | 0.10% |
Frequently asked questions
Who is the largest shareholder of Dr. Reddy's Laboratories?
Robeco Institutional Asset Management B.V. is the largest institutional shareholder of RDY, owning 2.16% of shares outstanding (18.02M shares) as of its latest 13F filing.
What percentage of Dr. Reddy's Laboratories is owned by institutions?
Institutions own about 16.0% of RDY shares and 16.0% of the public float.
How much of Dr. Reddy's Laboratories do insiders own?
Insiders, such as officers and directors, own about 0.00% of RDY shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.